U.S. Beverage Stock News

For investors wondering whether Enova International at around US$168 per share still offers value or if the best of the opportunity is already behind it, this article focuses squarely on what the current price might be implying. The stock has recent returns of 7.6% over 7 days, 22.4% over 30 days, 3.8% year to date, 77.4% over 1 year and 303.4% over 3 years. This naturally raises questions about how much optimism is already reflected in the price. Recent attention on Enova International has...

Credo Technology Group Holding recently presented its OmniConnect Weaver memory solution and 224G PAM4 SerDes IP at TSMC’s 2026 North America Technology Symposium in Santa Clara, while advancing a proposed US$750 million acquisition of DustPhotonics to expand its silicon photonics and optical connectivity capabilities for AI data centers. By pairing its high-speed SerDes portfolio with DustPhotonics’ silicon photonics platform, Credo is aiming to offer a more integrated copper-and-optical...

Why Estée Lauder Companies Stock Is Back On Investors’ Radar Estée Lauder Companies (EL) has drawn fresh attention as investors reassess the beauty group after a challenging stretch for the share price over the past 3 months and the past year. See our latest analysis for Estée Lauder Companies. The recent 1 day share price return of 1.05% and 7 day share price return of 0.08% sit against a 90 day share price return decline of 35.84% and a 5 year total shareholder return decline of 73.86%...

Williams Companies recently held a groundbreaking ceremony at Brooklyn’s Floyd Bennett Field to mark the start of construction on its Northeast Supply Enhancement project, an expansion of the Transco pipeline system that will add 400,000 dekatherms per day of natural gas capacity across Pennsylvania, New Jersey and New York by late 2027. By using electric motor-driven compressors and modern materials to lower emissions and noise while supporting thousands of jobs and regional energy...

In April 2026, Intapp, Inc. and DCM Insights expanded their partnership by embedding DCM’s Activator research-based business development playbooks directly into the Intapp Celeste agentic AI platform for professional and financial services firms. This move ties Harvard Business Review-backed behavior research to AI-driven “next-best actions,” aiming to turn partners’ business development efforts into consistent, measurable habits across client-facing teams. Next, we’ll examine how...

Earlier this week, Freeport-McMoRan posted its first-quarter 2026 financial and operating results and held a webcast with analysts to discuss the update. Alongside the results, the company cut its 2026 production outlook for the Grasberg mine and outlined a multi-year path back toward higher operating rates, reshaping expectations around one of its key assets. Next, we’ll examine how the reduced Grasberg production guidance might influence Freeport-McMoRan’s longer-term investment narrative...

Southern Copper (SCCO) moved back into focus after the unexpected passing of President and CEO Oscar Gonzalez Rocha on April 7, 2026. The event raised questions about leadership continuity and near term priorities. See our latest analysis for Southern Copper. Southern Copper's share price has been volatile around the leadership news, with a 1 month share price return of 17.62% and a year to date share price return of 27.32%. The 1 year total shareholder return of 116.97% and 5 year total...

Earlier this week, DXP Enterprises gained investor attention after peer Genuine Parts Company reported first-quarter 2026 results ahead of expectations, lifting sentiment across the industrial distribution space. The reaction highlighted how DXP’s outlook is often influenced not only by its own fundamentals but also by read‑throughs from sector peers’ earnings. Next, we’ll explore how stronger sector sentiment from Genuine Parts’ earnings beat may influence DXP Enterprises’ investment...

European Union approval of mCOMBRIAX, described as the world’s first combined influenza and COVID-19 vaccine. Planned launch of a Phase 3 clinical trial for Moderna’s H5 bird flu vaccine, supported by CEPI. Upcoming presentations of mRNA oncology data at ASCO 2026. For investors watching Moderna (NasdaqGS:MRNA), these updates arrive with the stock at $55.6 and a mixed return profile. The shares are up 2.5% over the past week, 8.4% over the past month and 80.2% year to date, while the 1 year...

ARMOUR Residential REIT, Inc. has reported first-quarter 2026 results showing a net loss of US$54.85 million, or basic and diluted loss per share of US$0.49, compared with net income a year earlier, while also affirming a monthly cash dividend of US$0.24 per common share payable on May 28, 2026. Despite the shift to a quarterly net loss, ARMOUR highlighted US$90.5 million of distributable earnings available to common stockholders and reiterated its focus on maintaining liquidity, capital...

Why VICI Properties is on investors’ radars today VICI Properties (VICI) continues to attract attention as a large-cap experiential real estate investment trust, with a portfolio of US$4.0b in annual revenue and exposure to gaming, hospitality, wellness and entertainment real estate. For investors watching income oriented real estate, the stock’s recent month return of about 4.3% contrasts with a roughly flat past 3 months move, while the 1 year total return sits near an 8.5% decline. See our...

Investors may be wondering if DHT Holdings at around US$17.74 still offers value after a strong run, or if most of the opportunity is already priced in. The stock shows a 0.5% return over the past week, roughly flat at 0.2% over 30 days, while the year-to-date return is 51.1% and the 1-year return is 85.8%, with 3-year and 5-year returns of 144.5% and 308.7% respectively. Recent coverage has focused on DHT Holdings as an established player in the energy shipping space, with attention on how...

Earlier in April 2026, Raymond James upgraded Axos Financial, Inc. to Strong Buy, while S&P Global ranked Axos Bank the fourth-highest performing publicly traded U.S. bank in 2025, citing its execution in profitability, growth, and risk management. Together, the analyst upgrade and S&P Global recognition spotlight Axos’s operating discipline and risk controls, reinforcing confidence in its digital-focused banking model. Next, we’ll examine how S&P Global’s high performance ranking could...

For investors considering whether Terex at around US$61 still offers value or if most of the upside is already reflected in the price, this article walks through what the current valuation suggests for you as a shareholder or potential investor. The stock has recorded returns of 4.1% over 7 days, 2.6% over 30 days, 11.0% year to date, and 79.6% over 1 year. This naturally raises questions about how much of the story is now priced in and how risk is being perceived. Recent news coverage...

AbCellera Biologics (ABCL) has drawn fresh attention after announcing plans to share interim Phase 1 data for its menopause therapy candidate ABCL635 during its first quarter 2026 earnings call on May 11. See our latest analysis for AbCellera Biologics. The recent ABCL635 update comes after a mixed stretch for the stock, with a 21.07% 1 month share price return and 18.95% year to date share price return contrasting with a 12.07% 3 month decline. The 61.26% 1 year total shareholder return...

If you are wondering whether American Tower's current share price reflects its true worth, you are not alone. This article focuses squarely on what the numbers say about valuation. The stock recently closed at US$176.31, with returns of 0.9% year to date but a 14.0% decline over the last year and a 2.4% decline over three years, which may have some investors reassessing both upside potential and risk. Recent coverage has focused on American Tower's role as a specialized REIT and how changing...

If you are trying to figure out whether WaterBridge Infrastructure at around US$27.83 is genuinely good value or just riding a story, the next sections will help you break that question down clearly. The stock has recently posted returns of 5.0% over 7 days, 8.2% over 30 days and 41.1% year to date, which may have shifted how the market views its potential and risk. Recent coverage of WaterBridge Infrastructure has focused on its role in the energy services space and its position within...

If you are wondering whether Newmont at around US$111.85 is still good value after a strong run, this article will walk through what the numbers actually say about the stock. The share price has produced a 10.5% year to date return, a 14.0% return over 30 days and a 113.2% return over 1 year, even after a 1.1% decline over the last week. Recent coverage has focused on Newmont in the context of gold producers, with attention on how its scale, asset base and capital allocation decisions set it...

Kailera Therapeutics completed its IPO and began trading on the Nasdaq Global Select Market under the ticker NasdaqGS:KLRA. The company has been added to the NASDAQ Composite Index, broadening its exposure to index-tracking investors. Shares most recently closed at $24.30, with a year-to-date return reflecting a 6.5% decline. Kailera Therapeutics, now trading as NasdaqGS:KLRA, has moved from private funding into the public markets with its Nasdaq Global Select Market listing. With a...

SoCalGas, a Sempra subsidiary, released a report indicating inflation adjusted residential natural gas rates were roughly 25% lower in 2023 than in 2000. The report highlights the role of natural gas infrastructure in helping keep energy affordable and maintaining reliability during periods of volatility. SoCalGas positions natural gas as an important support for California's transition to higher renewable energy use and grid stability. Sempra (NYSE:SRE), recently trading around $92.38,...

W. R. Berkley (WRB) opened 2026 with Q1 total revenue of US$3.7b, basic EPS of US$1.31 and net income of US$515.2m, with underwriting profitability reflected in a combined ratio of 90.7%. Over the past year, the company has seen total revenue move from US$13.6b to US$14.9b on a trailing twelve month basis, while trailing EPS shifted from US$4.39 to US$4.74. This gives a clear view of how the top and bottom line have tracked together as margins held in a tight band. See our full analysis for...

Hercules Capital, a business development company focused on debt financing for growth-stage technology and life sciences firms, recently reported quarterly results that showed 12.8% year-on-year revenue growth but a miss on both revenue and EPS versus analyst expectations. The company has also scheduled its first quarter 2026 financial results call for May 5, 2026, offering investors a timely opportunity to assess how management explains the latest earnings shortfall against prior...

In April 2026, Ulta Beauty and Google announced Gemini-enabled AI shopping tools that integrate Ulta’s assortment into Google’s conversational interfaces and power a new “Ulta AI” assistant on Ulta’s own digital platforms, aiming to make product discovery and checkout more seamless and personalized. By pairing Google’s AI infrastructure with insights from more than 46 million Ulta Beauty loyalty members, these tools could materially influence how beauty shoppers research, compare and...

How PulteGroup’s Recent Performance Frames the Investment Question PulteGroup (PHM) has drawn renewed attention after recent share price moves, with a 1 day return of about a 1% decline contrasting with gains over the past week and month. This has prompted a closer look at the homebuilder’s fundamentals. The company’s US focused operations span homebuilding and related financial services, with trailing 1 year total return of 27% and 3 year total return above 100%. That mix of short term...